Talk:Rasna: Difference between revisions
Dridhabala (talk | contribs) No edit summary |
Dridhabala (talk | contribs) No edit summary |
||
| Line 29: | Line 29: | ||
}} | }} | ||
'''[https://en.wikipedia.org/wiki/Pluchea_lanceolata Pluchea lanceolata Oliv.]''', popularly known as '''Rasna''', is a xerophytic perennial herb native to dry and semi-arid regions of India and South Asia. It is highly revered in [[Ayurveda]] as a primary drug of choice for managing painful inflammatory musculoskeletal conditions, particularly Vata disorders and rheumatoid arthritis. | '''[https://en.wikipedia.org/wiki/Pluchea_lanceolata Pluchea lanceolata Oliv.]''', popularly known as '''Rasna''', is a xerophytic perennial herb native to dry and semi-arid regions of India and South Asia. It is highly revered in [[Ayurveda]] as a primary drug of choice for managing painful inflammatory musculoskeletal conditions, particularly Vata disorders and Amavata (rheumatoid arthritis). Modern experimental studies have examined its anti-inflammatory, immunosuppressive, antioxidant, antimalarial, anti-asthmatic and neuro-inflammatory-modulating effects; these are summarised below together with its classical description.<ref name="Srivastava2012">Srivastava P, Shanker K. Pluchea lanceolata (Rasana): Chemical and biological potential of Rasayana herb used in traditional system of medicine. Fitoterapia. 2012;83(8):1371–1385. doi:10.1016/j.fitote.2012.07.008. PMID: 22877846</ref> | ||
== English name == | == English name == | ||
| Line 46: | Line 46: | ||
== Botanical Profile & Traditional Context == | == Botanical Profile & Traditional Context == | ||
In traditional Indian medicine | Pluchea lanceolata is an erect, perennial undershrub growing up to 30–100 cm in height, with a cylindrical, hairy, branched stem and simple, alternate, oblong to lanceolate leaves. In traditional Indian medicine it is described as an antipyretic, analgesic, bitter, laxative and nervine tonic, and is used for dyspepsia, bronchitis and rheumatoid arthritis.<ref name="Khan2010">Khan S, Rawat R, Rawat AKS, Shirwaikar A. A report on the quality control parameters of aerial parts of Pluchea lanceolata (DC.) Oliv. & Hiern, Asteraceae. Revista Brasileira de Farmacognosia. 2010;20. Available from: https://www.scielo.br/j/rbfar/a/vpXGbMFB45qRpt6V76tyhQn/?lang=en</ref> | ||
== Synonyms in Charak Samhita == | == Synonyms in Charak Samhita == | ||
| Line 131: | Line 131: | ||
Available in India: Karnataka, Kerala, Andhra Pradesh, Punjab. | Available in India: Karnataka, Kerala, Andhra Pradesh, Punjab. | ||
== | == Phytoconstituents == | ||
=== Triterpenoids, sterols and flavonoids === | |||
Constituents reported to have been isolated from the plant include the triterpenoids α-amyrin, β-amyrin caproate, moretenol, moretenol acetate, neolupenol and ψ-taraxasterol acetate; the sterol stigmasterol; and the flavonoids quercetin and isorhamnetin. Preliminary screening of aerial-part extracts showed proteins, starch, fixed oil, steroids, glycosides, triterpenoids and flavonoids, with a total flavonoid content of 67.24 ± 1.4 µg/mL in the samples studied.<ref name="Khan2010"/> | |||
= | === Volatile oil (aerial parts) === | ||
=== | GC-MS and NMR analysis of the hydrodistilled essential oil of the aerial parts identified oxygenated monoterpenes (53.4%) as the major group. The principal components were linalool (32.2%), β-caryophyllene (8.5%), α-terpineol (8.0%), spathulenol (7.4%) and linalyl acetate (5.6%).<ref name="Srivastava2015">Srivastava P, Jyotshna, Chanda D, Shanker K. Chemical characterization and acetylcholinesterase inhibition potential of volatile components of aerial parts of Pluchea lanceolata (DC.) Oliv. & Hiern. Records of Natural Products. 2015;9(4):586–591.</ref> | ||
== | == Therapeutic Efficacy: Pharmacological Evidence == | ||
The evidence summarised below is preclinical (animal and in vitro studies). No controlled human clinical trial of ''Pluchea lanceolata'' alone was found during the preparation of this monograph. | |||
=== | === Anti-inflammatory activity === | ||
A chemical investigation of the plant, carried out alongside anti-inflammatory evaluation, supported the traditional use of Rasna in inflammatory conditions.<ref name="Chawla1991">Chawla AS, Kaith BS, Handa SS, Kulshreshtha DK, Srimal RC. Chemical investigation and anti-inflammatory activity of Pluchea lanceolata. Fitoterapia. 1991;62(5):441–444.</ref> | |||
== | === Anti-arthritic, analgesic and antipyretic activity === | ||
A comprehensive review of the plant's chemistry and pharmacology records anti-inflammatory and anti-arthritic activity, along with analgesic, laxative and antipyretic activities, and attributes the anti-inflammatory effect mainly to its triterpenoids. This agrees with the classical use of Rasna in Amavata and Vatavyadhi, though the review-level evidence is not a substitute for clinical trials.<ref name="Srivastava2012"/> | |||
== | === Immunosuppressive and immunomodulatory activity === | ||
* | In Balb/c mice, a 50% ethanolic leaf extract reduced the humoral antibody response and delayed-type hypersensitivity, and also decreased phagocytosis and delayed skin-graft rejection. Its chloroform fraction (25–200 mg/kg, orally) significantly suppressed CD8+/CD4+ T-cell surface markers and the intracellular Th1 cytokines IL-2 and IFN-γ. The authors concluded that the plant acts by inhibiting Th1 cytokines, which is relevant to autoimmune joint disease.<ref name="Bhagwat2010">Bhagwat DP, Kharya MD, Bani S, Kaul A, Kour K, Chauhan PS, Suri KA, Satti NK. Immunosuppressive properties of Pluchea lanceolata leaves. Indian Journal of Pharmacology. 2010;42(1):21–26. doi:10.4103/0253-7613.62405</ref> | ||
* | |||
=== Neuro-inflammation (Vata disorders) === | |||
In LPS-stimulated rat astrocytoma (C6) cells, the triterpene taraxasterol, isolated from the plant, significantly reduced the release of TNF-α, IFN-γ and IL-6. Its acetate derivative did not inhibit IL-6 at lower concentrations. This offers an experimental basis for the traditional use of Rasna in neurological (Vata) disorders.<ref name="Srivastava2014">Srivastava P, Mohanty S, Bawankule DU, Khan F, Shanker K. Effect of Pluchea lanceolata bioactives in LPS-induced neuroinflammation in C6 rat glial cells. Naunyn-Schmiedeberg's Archives of Pharmacology. 2014;387(2):119–127.</ref> | |||
=== Acetylcholinesterase inhibition === | |||
The hydrodistilled volatile oil of the aerial parts inhibited acetylcholinesterase in mouse brain homogenate with an IC<sub>50</sub> of 2.54 ± 0.03 µg/mL, compared with 1.03 µg/mL for the reference drug physostigmine.<ref name="Srivastava2015"/> | |||
=== Anti-asthmatic activity (Swasa, Kasa) === | |||
In isolated guinea pig tracheal chain, the ethyl acetate fraction of the leaf extract (100 µg/mL) significantly reduced histamine-induced contraction; the maximum contraction fell from 100% in controls to 57.81 ± 1.22%. This is an in vitro finding and has not been confirmed in clinical studies.<ref name="Arora2011">Arora R, Gill NS, Dhingra VK, Rana AC. Evaluation of anti-asthmatic potential of ethyl acetate fraction of Pluchea lanceolata. Pharmacologyonline. 2011;2:1126–1133.</ref> | |||
=== Antimalarial activity (Jvara) === | |||
The hexane extract and taraxasterol acetate showed antimalarial activity against ''Plasmodium falciparum'' in vitro and ''P. berghei''-infected mice in vivo. Taraxasterol acetate also inhibited pro-inflammatory cytokines and raised blood glucose and haemoglobin levels in infected mice. No synergy with chloroquine was seen.<ref name="Mohanty2013">Mohanty S, Srivastava P, Maurya AK, Cheema HS, Shanker K, Dhawan S, Darokar MP, Bawankule DU. Antimalarial and safety evaluation of Pluchea lanceolata (DC.) Oliv. & Hiern: in-vitro and in-vivo study. Journal of Ethnopharmacology. 2013;149(3):797–802. PMID: 23954323</ref> | |||
=== Antioxidant and protective activity === | |||
In mice challenged with benzo(a)pyrene, pretreatment with the plant extract (100 and 200 mg/kg) restored renal glutathione and its dependent enzymes, increased catalase and quinone reductase, reduced micronuclei formation in bone marrow cells, and restored DNA integrity.<ref name="Jahangir2013">Jahangir T, Safhi MM, Sultana S, Ahmad S. Pluchea lanceolata protects against benzo(a)pyrene induced renal toxicity and loss of DNA integrity. Interdisciplinary Toxicology. 2013;6(1):47–54. doi:10.2478/intox-2013-0009</ref> | |||
== Safety, Toxicity, and Precautions == | |||
* '''Toxicity:''' The hexane extract was reported as non-toxic at higher concentrations in in vitro and in vivo safety evaluation.<ref name="Mohanty2013"/> No formal human safety data were found. | |||
* '''Precautions (inference, not from a cited study):''' Because the extract showed immunosuppressive activity in mice, caution is reasonable in patients taking immunosuppressant drugs. Data on use in pregnancy, lactation and children are lacking, and people with known sensitivity to the Asteraceae (Compositae) family should be watchful for allergic reactions. | |||
== Summary of Therapeutic Profile == | == Summary of Therapeutic Profile == | ||
{| class="wikitable sortable" style="text-align: left;" | {| class="wikitable sortable" style="text-align: left;" | ||
|+ Therapeutic Applications of | |+ Therapeutic Applications of ''Pluchea lanceolata'' (preclinical evidence) | ||
! Indication | ! Indication !! Experimental finding !! Type of evidence | ||
|- | |||
| '''Amavata / joint inflammation''' || Anti-inflammatory and anti-arthritic activity; Th1 cytokine suppression || Review; mouse study | |||
|- | |||
| '''Vatavyadhi (neurological disorders)''' || Reduced TNF-α, IFN-γ and IL-6 (taraxasterol); acetylcholinesterase inhibition (volatile oil) || Cell culture; ex vivo | |||
|- | |- | ||
| ''' | | '''Swasa / Kasa (asthma, cough)''' || Reduced histamine-induced tracheal contraction || Isolated guinea pig trachea | ||
| | |||
| | |||
|- | |- | ||
| ''' | | '''Jvara (fever, malaria-like fever)''' || Antimalarial activity of hexane extract and taraxasterol acetate || In vitro; mouse model | ||
| | |||
| | |||
|- | |- | ||
| ''' | | '''Oxidative stress / DNA damage''' || Restored renal antioxidant enzymes and DNA integrity || Mouse model | ||
| | |||
| | |||
|} | |} | ||
| Line 182: | Line 190: | ||
<ref name="Tripathi2006">Dr. Indradev Tripathi , Raja Nighantu of pandit Narhari, ed.2006, Chaukhambha Krishnadas Academy, Varanasi, pippalyadi varga 81</ref> | <ref name="Tripathi2006">Dr. Indradev Tripathi , Raja Nighantu of pandit Narhari, ed.2006, Chaukhambha Krishnadas Academy, Varanasi, pippalyadi varga 81</ref> | ||
<ref name="Bhavamishra2020">Shri Bhavamishra, Bhavaprakash Nighantu, Haritakyadi Varga, Verse no. 162, Edited by Padmashree Pro. Krushnachandra Chunekar, Reprint Edition, Chaukhambha Bharati Academy, 2020;</ref> | <ref name="Bhavamishra2020">Shri Bhavamishra, Bhavaprakash Nighantu, Haritakyadi Varga, Verse no. 162, Edited by Padmashree Pro. Krushnachandra Chunekar, Reprint Edition, Chaukhambha Bharati Academy, 2020;</ref> | ||
<ref name=" | <ref name="Srivastava2012">Srivastava P, Shanker K. Pluchea lanceolata (Rasana): Chemical and biological potential of Rasayana herb used in traditional system of medicine. Fitoterapia. 2012;83(8):1371–1385. doi:10.1016/j.fitote.2012.07.008. PMID: 22877846</ref> | ||
<ref name=" | <ref name="Khan2010">Khan S, Rawat R, Rawat AKS, Shirwaikar A. A report on the quality control parameters of aerial parts of Pluchea lanceolata (DC.) Oliv. & Hiern, Asteraceae. Revista Brasileira de Farmacognosia. 2010;20. Available from: https://www.scielo.br/j/rbfar/a/vpXGbMFB45qRpt6V76tyhQn/?lang=en</ref> | ||
<ref name=" | <ref name="Srivastava2015">Srivastava P, Jyotshna, Chanda D, Shanker K. Chemical characterization and acetylcholinesterase inhibition potential of volatile components of aerial parts of Pluchea lanceolata (DC.) Oliv. & Hiern. Records of Natural Products. 2015;9(4):586–591.</ref> | ||
<ref name="Chawla1991">Chawla AS, Kaith BS, Handa SS, Kulshreshtha DK, Srimal RC. Chemical investigation and anti-inflammatory activity of Pluchea lanceolata. Fitoterapia. 1991;62(5):441–444.</ref> | |||
<ref name="Bhagwat2010">Bhagwat DP, Kharya MD, Bani S, Kaul A, Kour K, Chauhan PS, Suri KA, Satti NK. Immunosuppressive properties of Pluchea lanceolata leaves. Indian Journal of Pharmacology. 2010;42(1):21–26. doi:10.4103/0253-7613.62405</ref> | |||
<ref name="Srivastava2014">Srivastava P, Mohanty S, Bawankule DU, Khan F, Shanker K. Effect of Pluchea lanceolata bioactives in LPS-induced neuroinflammation in C6 rat glial cells. Naunyn-Schmiedeberg's Archives of Pharmacology. 2014;387(2):119–127.</ref> | |||
<ref name="Arora2011">Arora R, Gill NS, Dhingra VK, Rana AC. Evaluation of anti-asthmatic potential of ethyl acetate fraction of Pluchea lanceolata. Pharmacologyonline. 2011;2:1126–1133.</ref> | |||
<ref name="Mohanty2013">Mohanty S, Srivastava P, Maurya AK, Cheema HS, Shanker K, Dhawan S, Darokar MP, Bawankule DU. Antimalarial and safety evaluation of Pluchea lanceolata (DC.) Oliv. & Hiern: in-vitro and in-vivo study. Journal of Ethnopharmacology. 2013;149(3):797–802. PMID: 23954323</ref> | |||
<ref name="Jahangir2013">Jahangir T, Safhi MM, Sultana S, Ahmad S. Pluchea lanceolata protects against benzo(a)pyrene induced renal toxicity and loss of DNA integrity. Interdisciplinary Toxicology. 2013;6(1):47–54. doi:10.2478/intox-2013-0009</ref> | |||
}} | }} | ||
[[Category: Database of herbs and minerals | Herbs]] | [[Category: Database of herbs and minerals | Herbs]] | ||